✦ LIBER ✦

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

✍ Scribed by Samer Bibawi; Dima Abi-Said; Luis Fayad; Paolo Anderlini; Naoto T. Ueno; Rakesh Mehra; Issa Khouri; Sergio Giralt; James Gajewski; Michelle Donato; David Claxton; Ira Braunschweig; Koen van Besien; Michael Andreeff; Borje S. Andersson; Elihu H. Estey; Richard Champlin; Donna Przepiorka

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 53 KB
Volume: 67
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.1121

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thiotepa, busulfan, and cyclophosphamide

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity

✍ D. Przepiorka; M. Dimopoulos; T. Smith; C. Ippoliti; K. Diener; M. Luna; R. E. C 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 578 KB

Cost and effectiveness of reduced-intens

Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome

✍ Osamu Imataki; Takeshi Kamioka; Takashi Fukuda; Ryuji Tanosaki; Yoichi Takaue 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 163 KB

High dose cyclophosphamide, BCNU, and VP

High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia

✍ Axel R. Zander; Steven Culbert; Sundar Jagannath; Gary Spitzer; Michael Keating; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 2 views

Unrelated donor bone marrow transplantat

✍ Lois J. Ayash; Voravit Ratanatharathorn; Thomas Braun; Samuel M. Silver; Christo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the pediatric blood and marrow transplant consortium

✍ Sandler, E.S. ;Hagg, R. ;Coppes, M.J. ;Mustafa, M.M. ;Gamis, A. ;Kamani, N. ;Wal 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 3 views

Maintenance therapy with low-dose azacit

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome : A dose and schedule finding study

✍ Marcos de Lima; Sergio Giralt; Peter F. Thall; Leandro de Padua Silva; Roy B. Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 1 views